Functional deficiency of succinate dehydrogenase promotes tumorigenesis and development of clear cell renal cell carcinoma through weakening of ferroptosis. Issue 4 (1st April 2022)

• Record Type: Journal Article
• Authors: Yang, Jing; Zhou, Yi; Li, Yanchun; Hu, Wanye; Yuan, Chen; Chen, Shida; Ye, Gaoqi; Chen, Yuzhou; Wu, Yunyi; Liu, Jing; Wang, Ying; Du, Jing; Tong, Xiangmin
• Is Part Of: Bioengineered. Volume 13:Issue 4(2022)
• Page Start: 11187
• Page End: 11207
• Publication Date: 2022-04-01
• Subjects: Succinate dehydrogenase -- renal cell carcinoma -- prognosis -- ferroptosis -- oxidative phosphorylation; Biomedical engineering -- Periodicals; Biotechnology -- Periodicals; Microbiology -- Periodicals; 660.6
• DOI: 10.1080/21655979.2022.2062537
• Languages: English
• ISSNs: 2165-5987

Abstract

ABSTRACT: Clear cell renal cell carcinoma (ccRCC) is the most common subtype of renal carcinomas, with high mortality and poor prognoses worldwide. Succinate dehydrogenase (SDH) consists of four nuclear-encoded subunits and it is the only complex involved in both the tricarboxylic acid (TCA) cycle and oxidative phosphorylation (OXPHOS). Previous studies have shown decreased SDH activity in ccRCC. However, the role and underlying molecular mechanisms of SDH in ccRCC initiation and development remain unclear. In the present study, pan-cancer analysis of SDH gene expression was analyzed and the relationship between SDH gene expression and clinicopathological parameters was assessed using different databases. cBioPortal, UACLAN, and Tumor Immune Estimation Resource (TIMER) were subsequently utilized to analyze genetic alterations, methylation, and immune cell infiltration of SDH genes in ccRCC patients. We found SDHs were significantly downregulated in ccRCC tissues and correlated with ccRCC progression. Increased methylation and high SDH promoter mutation rates may be the cause of reduced expression of SDHs in ccRCC. Moreover, the interaction network showed that SDH genes were correlated with ferroptosis-related genes. We further demonstrated that SDH inhibition dampened oxidative phosphorylation, reduced ferroptotic events, and restored ferroptotic cell death, characterized by eliminated mitochondrial ROS levels, decreased cellular ROS and diminished peroxide accumulation. Collectively, this study provides new insights into the regulatory role of SDH in the carcinogenesis and progression of ccRCC, introducing a potential target for advanced antitumor therapy through ferroptosis. Graphical Abstract: uf0001